查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1883810

全球登革热检测市场

Dengue Testing
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 158 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球登革热检测市场规模将达到7.407亿美元。

2024年全球登革热检测市场规模估计为5.576亿美元，预计到2030年将达到7.407亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.8%。本报告分析的细分市场之一－医院终端用户市场，预计复合年增长率为5.8%，到分析期末将达到3.678亿美元。诊断中心终端用户细分市场预计在分析期间内复合年增长率为4.5%。

美国市场规模估计为1.49亿美元，而中国市场预计将以8.3%的复合年增长率成长。

据估计，2024年美国登革热检测市场规模将达1.49亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.613亿美元，在2024年至2030年的分析期内，复合年增长率（CAGR）为8.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.4%和4.0%。在欧洲，德国的复合年增长率预计约为3.1%。

全球登革热检测市场－主要趋势与驱动因素概述

什么是登革热？为什么准确检测至关重要？

登革热是一种主要流行于全球热带和亚热带地区的蚊媒病毒性疾病，对公共卫生构成重大挑战。它是由四种登革病毒血清型中的一种引起，可导致多种症状，从轻微发烧到严重的类流感症状。严重病例可发展为可能致命的登革出血热或登革热休克症候群。准确检测登革热不仅对正确的临床治疗至关重要，而且对预防疾病传播也至关重要。早期诊断有助于有效控制症状，并防止病情发展为更严重的类型。此外，在流行地区区分登革热与其他发烧疾病对于制定有针对性的公共卫生应对措施和高效分配资源至关重要。

登革热检测的实施方式及相关技术

登革热检测依疾病阶段采用多种调查方法。在早期阶段，RT-PCR 检测可检测病毒 RNA。此检测具有较高的特异性，并能辨识病毒血清型。随着疾病进展，ELISA（酵素免疫分析法）检测抗体成为重点。此检测可区分 IgM 和 IgG 抗体。 IgM 抗体通常在症状出现后约 5 天即可检测到，显示近期感染。而 IgG 抗体出现较晚，可能表示先前感染或不同血清型的二次感染。快速诊断检测 (RDT) 也已研发成功，由于其操作简单、结果快速，在资源匮乏地区非常实用。然而，其特异性通常低于实验室检测。

登革热检测面临哪些挑战？

儘管诊断技术取得了进步，但登革热检测仍面临许多挑战。其中一个主要问题是与其他黄病毒（例如兹卡病毒和基孔肯雅病毒）的交叉反应，这可能导致误诊。在这些病毒共同流行的地区，这个问题尤其突出。另一个挑战是检测的敏感度和特异性存在差异，尤其是在快速诊断检测中，这可能导致假阴性或假阳性结果。这种不准确性会对患者照护和疾病监测产生严重影响。此外，病毒和抗体的检测窗口期相对较短，因此需要及时检测，但这在偏远或医疗资源匮乏的地区并非总是可行。这些挑战凸显了持续进行研发工作以提高登革热检测方法的准确性、可及性和可靠性的必要性。

登革热检测市场的成长要素是什么？

登革热检测市场的成长受多种因素驱动，其中包括全球登革热发病率的上升。国际旅行的增加以及有利于蚊虫滋生的气候条件，导致登革热的传播超越了传统的地理界限，从而增加了对诊断检测的需求。旨在控制登革热传播的公共卫生措施也推动了这项需求，尤其是在实施严格监测和控制措施的流行地区。生物技术的进步，例如开发出更快、更准确、更经济的检测方法，也是成长要素。此外，人们对登革热的经济和健康影响的认识不断提高，促使公共和私人部门加大对预防保健和诊断技术的投资。最后，新冠肺炎疫情提高了全球对感染疾病的关注度，并凸显了快速且准确检测的重要性，进一步刺激了登革热诊断领域的投资和创新。这些技术、经济和社会因素共同确保了市场的强劲成长，反映出人们越来越重视发展公共卫生基础设施，以更有效地管理登革热和其他媒介传播疾病。

部分：

检测类型（基于 ELISA 的检测、基于 RT-PCR 的检测、快速登革热 IgG/IgM 检测）、最终用途（医院、诊断中心、公共卫生实验室、其他最终用途）

受访公司范例

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec SL
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在国、製造地以及进出口（成品和OEM产品）情况，预测企业竞争格局的变化。这种复杂多变的市场现实将对竞争对手产生多方面的影响，包括销货成本增加、盈利下降和供应链重组，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP11491

Global Dengue Testing Market to Reach US$740.7 Million by 2030

The global market for Dengue Testing estimated at US$557.6 Million in the year 2024, is expected to reach US$740.7 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$367.8 Million by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$149.0 Million While China is Forecast to Grow at 8.3% CAGR

The Dengue Testing market in the U.S. is estimated at US$149.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$161.3 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Dengue Testing Market - Key Trends and Drivers Summarized

What Is Dengue and Why Is Accurate Testing Crucial?

Dengue fever is a mosquito-borne viral disease prevalent primarily in tropical and subtropical climates worldwide, posing significant public health challenges. Caused by one of the four dengue virus serotypes, it presents a wide range of symptoms from mild fever to severe flu-like conditions, and in critical cases, it can progress to dengue hemorrhagic fever or dengue shock syndrome, which can be fatal. Accurate testing for dengue is crucial not only for appropriate clinical management but also for controlling the spread of the disease. Early diagnosis helps in managing the symptoms more effectively and can reduce the progression to more severe forms. Moreover, distinguishing dengue from other febrile illnesses in endemic regions is essential for targeted public health responses and efficient resource allocation.

How Are Dengue Tests Conducted and What Technologies Are Involved?

Dengue testing involves several methodologies that depend on the stage of the illness. In the early stages, viral RNA can be detected using RT-PCR tests, which are highly specific and can identify the virus serotype. As the disease progresses, the focus shifts to detecting antibodies using ELISA (enzyme-linked immunosorbent assay) tests that can differentiate between IgM and IgG antibodies. IgM antibodies are typically detectable from about five days after the onset of symptoms and indicate a recent infection, while IgG antibodies appear later and can indicate a past infection or enhancement due to secondary infection with a different serotype. Rapid diagnostic tests (RDTs) have also been developed, which are invaluable in resource-limited settings for their ease of use and quick turnaround times, although they generally offer less specificity than laboratory-based tests.

What Are the Challenges in Dengue Testing?

Despite advances in diagnostic technologies, dengue testing faces significant challenges. One major issue is the cross-reactivity with other flaviviruses such as Zika and chikungunya, which can lead to misdiagnosis. This is particularly problematic in regions where these viruses co-circulate. Another challenge is the variation in test sensitivity and specificity, especially among rapid diagnostic tests, which can lead to false negatives or false positives. Such inaccuracies can have severe implications for patient care and disease surveillance. Additionally, the window for detecting the virus or antibodies is relatively short, which necessitates timely testing that may not always be feasible in remote or underserved areas. These challenges underscore the need for ongoing research and development to enhance the accuracy, accessibility, and reliability of dengue testing methods.

What Drives the Growth in the Dengue Testing Market?

The growth in the dengue testing market is driven by several factors, beginning with the rising incidence of dengue worldwide. As global travel increases and climatic conditions favor mosquito breeding, dengue is expanding beyond traditional geographic boundaries, increasing the demand for diagnostic tests. Public health initiatives focused on controlling the spread of dengue also fuel this demand, particularly in endemic countries that are implementing more rigorous surveillance and control measures. Advances in biotechnology that have led to the development of faster, more accurate, and cost-effective tests are also significant growth drivers. Additionally, the growing awareness of the economic and health impacts of dengue has led to greater public and private sector investment in preventive care and diagnostics. Finally, the COVID-19 pandemic has heightened global attention on infectious diseases and the critical role of timely and accurate testing, further accelerating investment and innovation in the field of dengue diagnostics. These technological, economic, and social drivers ensure robust market growth, reflecting an increasing emphasis on improving public health infrastructure to manage dengue and other vector-borne diseases more effectively.

SCOPE OF STUDY:

The report analyzes the Dengue Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (ELISA-Based Tests, RT-PCR Based Tests, Dengue IgG / IgM Rapid Test); End-Use (Hospitals, Diagnostic Centers, Public Health Laboratory, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Dengue Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Dengue Fever Drives Demand for Effective Testing Solutions
    • Growing Public Health Initiatives to Combat Dengue Bolster Testing Market
    • Technological Advancements in Diagnostic Kits Enhance Rapid and Accurate Dengue Detection
    • Expansion of Healthcare Infrastructure in Endemic Regions Spurs Market Growth
    • Increasing Travel and Migration Amplify Risks and Demand for Dengue Testing
    • Expansion of Laboratory and In-Clinic Testing Capacities in Developing Countries
    • Increasing Use of Point-of-Care Testing Devices for Dengue in Remote Areas
    • Rising Demand for Molecular Diagnostic Tests for Early Dengue Detection
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for ELISA-Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Dengue IgG / IgM Rapid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Dengue Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION